Trial Profile
Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplant Recipients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Tacrolimus (Primary) ; Antithymocyte globulin; Mycophenolate mofetil; Prednisone
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 08 Apr 2009 New trial record